Short-rib thoracic dysplasia 21 without polydactyly
diseaseOn this page
Also known as SRTD21
Summary
Short-rib thoracic dysplasia 21 without polydactyly (MONDO:0030356) is a disease caused by KIAA0753 (GenCC Strong), with 1 cohort gene.
At a glance
- Causal gene: KIAA0753 (GenCC Strong)
- Cohort genes: 1
- ClinVar variants: 23
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | short-rib thoracic dysplasia 21 without polydactyly |
| Mondo ID | MONDO:0030356 |
| OMIM | 619479 |
| UMLS | C5561961 |
| MedGen | 1794171 |
| GARD | 0025550 |
| Is cancer (heuristic) | no |
Also known as: short-rib thoracic dysplasia 21 without polydactyly · SRTD21
Data availability: 23 ClinVar variants · 1 GenCC gene-disease record.
Disease family
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › ciliopathy › Jeune syndrome › short-rib thoracic dysplasia 21 without polydactyly
Related subtypes (23): asphyxiating thoracic dystrophy 1, Ellis-van Creveld syndrome, short-rib thoracic dysplasia 6 with or without polydactyly, short-rib thoracic dysplasia 9 with or without polydactyly, Beemer-Langer syndrome, asphyxiating thoracic dystrophy 2, asphyxiating thoracic dystrophy 3, asphyxiating thoracic dystrophy 4, short-rib thoracic dysplasia 7 with or without polydactyly, asphyxiating thoracic dystrophy 5, short-rib thoracic dysplasia 8 with or without polydactyly, short-rib thoracic dysplasia 10 with or without polydactyly, short-rib thoracic dysplasia 11 with or without polydactyly, short-rib thoracic dysplasia 13 with or without polydactyly, short-rib thoracic dysplasia 14 with polydactyly, short-rib thoracic dysplasia 15 with polydactyly, short-rib thoracic dysplasia 16 with or without polydactyly, short-rib thoracic dysplasia 19 with or without polydactyly, short-rib thoracic dysplasia 18 with polydactyly, short-rib thoracic dysplasia 20 with polydactyly, short-rib thoracic dysplasia 17 with or without polydactyly, Jeune syndrome - GRK2-related, short-rib thoracic dysplasia 22 without polydactyly
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
23 retrieved; paginated sample, class counts are floors:
9 benign, 4 pathogenic, 4 pathogenic/likely pathogenic, 2 likely pathogenic, 2 benign/likely benign, 1 conflicting classifications of pathogenicity, 1 likely benign
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 1196005 | NM_014804.3(KIAA0753):c.1830-2A>G | KIAA0753 | Pathogenic | no assertion criteria provided |
| 2427871 | NM_014804.3(KIAA0753):c.757C>T (p.Arg253Ter) | KIAA0753 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 428613 | NM_014804.3(KIAA0753):c.970C>T (p.Arg324Ter) | KIAA0753 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 428614 | NM_014804.3(KIAA0753):c.1271del (p.Pro424fs) | KIAA0753 | Pathogenic | no assertion criteria provided |
| 428615 | NM_014804.3(KIAA0753):c.943C>T (p.Gln315Ter) | KIAA0753 | Pathogenic | criteria provided, single submitter |
| 439846 | NM_014804.3(KIAA0753):c.1571_1572del (p.Arg524fs) | KIAA0753 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 620530 | NM_014804.3(KIAA0753):c.2656C>T (p.Arg886Ter) | KIAA0753 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 808212 | NM_014804.3(KIAA0753):c.661C>T (p.Arg221Ter) | KIAA0753 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 3377254 | NM_014804.3(KIAA0753):c.2675del (p.Pro892fs) | KIAA0753 | Likely pathogenic | criteria provided, single submitter |
| 4526596 | NM_014804.3(KIAA0753):c.1722del (p.Trp574fs) | KIAA0753 | Likely pathogenic | criteria provided, single submitter |
| 558755 | NM_014804.3(KIAA0753):c.810C>T (p.Tyr270=) | KIAA0753 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 1183823 | NM_014804.3(KIAA0753):c.69C>T (p.Ser23=) | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 1221496 | NM_014804.3(KIAA0753):c.507T>C (p.Ser169=) | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 1236419 | NM_014804.3(KIAA0753):c.2687A>G (p.Gln896Arg) | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 1238793 | NM_014804.3(KIAA0753):c.1697C>T (p.Pro566Leu) | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 1252198 | NM_014804.3(KIAA0753):c.1125A>T (p.Glu375Asp) | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 1259547 | NM_014804.3(KIAA0753):c.*21A>G | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 1278062 | NM_014804.3(KIAA0753):c.1397T>C (p.Leu466Pro) | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 1280830 | NM_014804.3(KIAA0753):c.1330G>A (p.Asp444Asn) | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 1284038 | NM_014804.3(KIAA0753):c.1716T>C (p.Ala572=) | KIAA0753 | Benign | criteria provided, multiple submitters, no conflicts |
| 376793 | NM_014804.3(KIAA0753):c.1756A>G (p.Lys586Glu) | KIAA0753 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts |
| 445434 | NM_014804.3(KIAA0753):c.2338C>T (p.Arg780Cys) | KIAA0753 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts |
| 713011 | NM_014804.3(KIAA0753):c.236T>C (p.Val79Ala) | KIAA0753 | Likely benign | criteria provided, multiple submitters, no conflicts |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 6 · Orphanet: 3 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| KIAA0753 | Strong | Autosomal recessive | short-rib thoracic dysplasia 21 without polydactyly | 6 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| KIAA0753 | Orphanet:2754 | Orofaciodigital syndrome type 6 |
| KIAA0753 | Orphanet:474 | Jeune syndrome |
| KIAA0753 | Orphanet:475 | Isolated Joubert syndrome |
Cohort genes → proteins
1 cohort genes, 1 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 1 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| KIAA0753 | HGNC:29110 | ENSG00000198920 | Q2KHM9 | Protein moonraker | gencc,clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| KIAA0753 | Protein moonraker | Involved in centriole duplication. |
Protein-family classification
Druggable: 0 · Difficult: 0 · Unknown: 1 · Druggable fraction: 0.0
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Other/Unknown | 1 | 1.8× | 0.558 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| KIAA0753 | Other/Unknown | no | MNR |
Expression context
Cohort genes with no expression data: 0.
1 cohort gene are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 1 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| cortical plate | 1 |
| lower esophagus | 1 |
| lower esophagus muscularis layer | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| KIAA0753 | 243 | ubiquitous | marker | cortical plate, lower esophagus, lower esophagus muscularis layer |
Protein interactions among cohort
Intra-cohort edges: 0.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| KIAA0753 | 1,062 |
Structural data
PDB: 0 · AlphaFold-only: 1 · No structure: 0
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| KIAA0753 | Q2KHM9 | 59.08 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 0. Enrichment computed across 1 evidence-associated genes (0 with Reactome annotation).
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| cytosolic ciliogenesis | 1 | 3370.4× | 0.001 | KIAA0753 |
| centriole replication | 1 | 732.7× | 0.002 | KIAA0753 |
| protein localization to centrosome | 1 | 674.1× | 0.002 | KIAA0753 |
| cilium assembly | 1 | 73.6× | 0.014 | KIAA0753 |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1
Druggability breadth: 0 of 1 evidence-associated genes (0%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| KIAA0753 | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Pharmacogenomics
Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 0 | |
| D | Druggable family + AlphaFold only, no drug | 0 | |
| E | Difficult family or no structure, no drug | 1 | KIAA0753 |
Undrugged target profiles
1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| KIAA0753 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
- Cohort genes: KIAA0753